BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17308799)

  • 21. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
    Bungiro RD; Goldberg M; Suri PK; Knopf PM
    Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
    Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
    Front Immunol; 2018; 9():2488. PubMed ID: 30450095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice.
    Zouain CS; Gustavson S; Oliveira SC; Azevedo V; Alves JB; Goes AM
    Vaccine; 2000 Dec; 19(9-10):1218-24. PubMed ID: 11137260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.
    Fonseca CT; Brito CF; Alves JB; Oliveira SC
    Vaccine; 2004 Jan; 22(3-4):503-10. PubMed ID: 14670333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization.
    Melo TT; Sena IC; Araujo N; Fonseca CT
    Parasite Immunol; 2014 Feb; 36(2):107-11. PubMed ID: 24558655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
    Mountford AP; Anderson S; Wilson RA
    J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
    Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
    Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis.
    El Ridi R; Mahrous A; Afifi A; Montash M; Velek J; Jezek J
    Scand J Immunol; 2001 Nov; 54(5):477-85. PubMed ID: 11696199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
    King CL; Malhotra I; Jia X
    Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gestation and breastfeeding in schistosomotic mothers differently modulate the immune response of adult offspring to postnatal Schistosoma mansoni infection.
    Santos Pd; Lorena VM; Fernandes Éde S; Sales IR; Nascimento WR; Gomes Yde M; Albuquerque MC; Costa VM; Souza VM
    Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):83-92. PubMed ID: 26872339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sm16, A
    Bernardes WPOS; de Araújo JM; Carvalho GB; Alves CC; de Moura Coelho AT; Dutra ITS; Teixeira SSF; de Azambuja Ribeiro RIM; de Moraes Mourão M; da Silva-Pereira RA; Fonseca CT
    J Immunol Res; 2019; 2019():6793596. PubMed ID: 31886307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.
    Torben W; Ahmad G; Zhang W; Siddiqui AA
    Vaccine; 2011 Mar; 29(12):2262-71. PubMed ID: 21277404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IgG antibodies from irradiated cercaria-immunized rabbits in the passive transfer of immunity to Schistosoma mansoni-infected mice.
    Mangold BL; Dean DA
    Am J Trop Med Hyg; 1992 Dec; 47(6):821-9. PubMed ID: 1471741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.